Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CA Stock MarketDetailed Quotes
Marvel Biosciences Corp (MRVL)
- 0.150
- -0.005-3.23%
15min DelayMarket Closed May 29 16:00 ET
9.45MMarket Cap-3.75P/E (TTM)
0.155High0.145Low19.00KVolume0.155Open0.155Prev Close2.89KTurnover0.40052wk High0.04%Turnover Ratio63.03MShares0.09052wk Low-0.04EPS TTM7.73MFloat Cap0.400Historical HighLossP/E (Static)51.52MShs Float0.010Historical Low-0.05EPS LYR6.45%Range %--Dividend TTM-2.46P/B1Lot Size--Div Yield TTM
Marvel Biosciences Corp (MRVL) Income Statement
Quarterly+Annual
YOY
| (Q2)Jan 31, 2026 | (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -98.16%5.26K | 402.99%57.46K | 81.23%547.37K | 1,391.25%250.56K | -98.73%382 | 554.97%285K | -94.60%11.42K | 302.02K | 16.8K | -88.19%30.04K |
| Gross profit | 98.16%-5.26K | -402.99%-57.46K | -81.23%-547.37K | -1,391.25%-250.56K | 98.73%-382 | -554.97%-285K | 94.60%-11.42K | -302.02K | -16.8K | 88.19%-30.04K |
| Operating expense | 145.06%265.63K | -6.65%205.9K | -27.69%701.32K | -70.08%97.43K | 32.37%274.94K | -48.01%108.39K | -3.30%220.56K | 969.86K | 325.6K | -52.56%207.7K |
| Selling and administrative expenses | 3.91%250.65K | -6.88%195.38K | 0.81%920.81K | -27.10%229.08K | 22.75%240.71K | 33.72%241.21K | -5.78%209.8K | --913.41K | --314.24K | -50.50%196.09K |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | --17.75K | -76.05%74.82K | -87.62%18K | -65.99%56.82K |
| -General and administrative expense | 3.91%250.65K | -6.88%195.38K | 0.81%920.81K | -27.10%229.08K | 22.75%240.71K | 33.72%241.21K | -5.78%209.8K | --913.41K | --314.24K | -14.39%196.09K |
| Other operating expenses | 111.28%14.98K | -2.16%10.52K | -488.81%-219.49K | -1,259.32%-131.65K | 194.85%34.23K | -572.77%-132.82K | 99.46%10.76K | --56.45K | --11.36K | -72.17%11.61K |
| Operating profit | 31.14%-270.89K | -13.53%-263.36K | 1.82%-1.25M | -1.63%-347.99K | -15.81%-275.32K | -56.11%-393.4K | 47.25%-231.98K | -1.27M | -342.4K | 65.65%-237.74K |
| Net non-operating interest income (expenses) | -57.42%-56.35K | -57.59%-56.4K | -133.44%-266.07K | -352.18%-161.7K | 6.47%-32.79K | -59.43%-35.8K | -72.83%-35.79K | -113.98K | -35.76K | -52.04%-35.06K |
| Non-operating interest income | ---- | ---- | --1.93K | --72 | --1.86K | ---- | ---- | --0 | --0 | --0 |
| Non-operating interest expense | 57.42%56.35K | 57.59%56.4K | 135.14%268.01K | 352.38%161.77K | -1.16%34.65K | 59.43%35.8K | 72.83%35.79K | 196.65%113.98K | 181.46%35.76K | 52.04%35.06K |
| Other net income (expenses) | 156.12%31.66K | -114.81%-22.51K | -163.69%-696.71K | -218.76%-680.52K | 246.90%50.7K | -235.49%-56.42K | 81.89%-10.48K | -264.22K | -213.49K | -3,177.59%-34.51K |
| Gain on sale of security | 156.12%31.66K | -114.81%-22.51K | 55.05%-24.37K | -134.18%-8.18K | 246.90%50.7K | -235.49%-56.42K | 81.89%-10.48K | ---54.22K | ---3.49K | -3,177.59%-34.51K |
| Special income (charges) | ---- | ---- | ---72.34K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Write off | ---- | ---- | --72.34K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | -185.71%-600K | ---- | ---- | ---- | ---- | ---210K | ---- | ---- |
| Income before tax | 39.13%-295.58K | -23.01%-342.26K | -34.02%-2.21M | -101.17%-1.19M | 16.24%-257.41K | -108.58%-485.61K | 46.32%-278.25K | -1.65M | -591.65K | 57.10%-307.31K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 39.13%-295.58K | -23.01%-342.26K | -34.02%-2.21M | -101.17%-1.19M | 16.24%-257.41K | -108.58%-485.61K | 46.32%-278.25K | 27.99%-1.65M | 43.43%-591.65K | 57.10%-307.31K |
| Net income continuous operations | 39.13%-295.58K | -23.01%-342.26K | -34.02%-2.21M | -101.17%-1.19M | 16.24%-257.41K | -108.58%-485.61K | 46.32%-278.25K | 27.99%-1.65M | 43.43%-591.65K | 57.10%-307.31K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 39.13%-295.58K | -23.01%-342.26K | -34.02%-2.21M | -101.17%-1.19M | 16.24%-257.41K | -108.58%-485.61K | 46.32%-278.25K | 27.99%-1.65M | 43.43%-591.65K | 57.10%-307.31K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 39.13%-295.58K | -23.01%-342.26K | -34.02%-2.21M | -101.17%-1.19M | 16.24%-257.41K | -108.58%-485.61K | 46.32%-278.25K | 27.99%-1.65M | 43.43%-591.65K | 57.10%-307.31K |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | -25.00%-0.05 | -200.00%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 33.33%-0.04 | 66.67%-0.01 | 0.00%-0.01 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | -25.00%-0.05 | -200.00%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 33.33%-0.04 | 66.67%-0.01 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 29, Eastern Time, Trump held a two-hour meeting in the White House Situation Room but has not yet reached a final decision on negotia
Futubull Options Sir
May 26 18:03
Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.